4.7 Article

High-level expression of early growth response-1 and association of polymorphism with total IgE and atopy in allergic rhinitis adults

Journal

CLINICA CHIMICA ACTA
Volume 411, Issue 1-2, Pages 67-71

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.cca.2009.10.005

Keywords

Allergic rhinitis; Egr-1; Genetic susceptibility; Immunoglobulin E; mRNA expression

Funding

  1. Chinese University of Hong Kong

Ask authors/readers for more resources

Background: Early growth response-1 (Egr-1) is expressed in human airways and its polymorphisms have been associated with total IgE and atopy in asthmatic patients. We investigated the effects of Chinese-tagging single nucleotide polymorphism (SNP) of Egr-1 and its mRNA expression on allergic rhinitis (AR) traits. Methods: Among 214 Chinese AR adults and 259 controls, tag SNP -4071 A -> G was genotyped and mRNA expression in peripheral blood was quantified by real-time PCR. Results: Egr-1 mRNA expression was significantly higher in patients than controls (median of 0.23 vs 0.15 fold GAPDH expression; p<0.001). Its expression was not associated with -4071 polymorphism. However, significant correlations were found between -4071 A -> G with increased plasma total IgE (p=0.028) and atopy (p=0.030) in patients. Logistic regression confirmed the association (p=0.034) with age and gender adjusted. Patients homozygous for the A allele had a 2.3-fold and 1.9-fold risks, respectively of having increased plasma total IgE and atopy than those G allele carriers. Conclusions: We showed high levels of Egr-1 mRNA expression and demonstrated a significant association of polymorphism with increased plasma total IgE and atopy in AR patients. It may be useful to explore the pharmacogenetics of Egr-1 inhibitors. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available